MedTrace Logo

C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance

NCT00589355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2020-04-17

No results posted yet for this study

Summary

The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.

Conditions

  • Glucose Intolerance

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Barbara I Gulanski, MD, MPH · Yale University

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2003-06-30
Completion
2008-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00589355 on ClinicalTrials.gov